RS51605B - 3-fenil supstituisani piridoindolon, njegova izrada i terapeutska upotreba - Google Patents

3-fenil supstituisani piridoindolon, njegova izrada i terapeutska upotreba

Info

Publication number
RS51605B
RS51605B YU20050362A YUP36205A RS51605B RS 51605 B RS51605 B RS 51605B YU 20050362 A YU20050362 A YU 20050362A YU P36205 A YUP36205 A YU P36205A RS 51605 B RS51605 B RS 51605B
Authority
RS
Serbia
Prior art keywords
ppm
group
compound
dihydro
phenyl
Prior art date
Application number
YU20050362A
Other languages
English (en)
Serbian (sr)
Inventor
Bernard Bourrie
Pierre Casellas
Paola Ciapetti
Jean-Marie Derocq
Samir Jegham
Yvette Muneaux
Camille-Georges Wermuth
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of RS20050362A publication Critical patent/RS20050362A/sr
Publication of RS51605B publication Critical patent/RS51605B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YU20050362A 2002-10-23 2003-10-21 3-fenil supstituisani piridoindolon, njegova izrada i terapeutska upotreba RS51605B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0213264A FR2846329B1 (fr) 2002-10-23 2002-10-23 Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
PCT/FR2003/003110 WO2004041817A1 (fr) 2002-10-23 2003-10-21 Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
RS20050362A RS20050362A (sr) 2007-11-15
RS51605B true RS51605B (sr) 2011-08-31

Family

ID=32088223

Family Applications (1)

Application Number Title Priority Date Filing Date
YU20050362A RS51605B (sr) 2002-10-23 2003-10-21 3-fenil supstituisani piridoindolon, njegova izrada i terapeutska upotreba

Country Status (32)

Country Link
US (2) US7390818B2 (https=)
EP (1) EP1556382B1 (https=)
JP (1) JP4488899B2 (https=)
KR (1) KR101051859B1 (https=)
CN (1) CN100345850C (https=)
AR (1) AR041689A1 (https=)
AT (1) ATE396994T1 (https=)
AU (1) AU2003296769B2 (https=)
BR (1) BR0314883A (https=)
CA (1) CA2502769C (https=)
CY (1) CY1109785T1 (https=)
DE (1) DE60321372D1 (https=)
DK (1) DK1556382T3 (https=)
EA (1) EA010833B1 (https=)
ES (1) ES2304546T3 (https=)
FR (1) FR2846329B1 (https=)
HR (1) HRP20050362B1 (https=)
IL (1) IL168133A (https=)
IS (1) IS2641B (https=)
MA (1) MA27455A1 (https=)
ME (1) ME00102B (https=)
MX (1) MXPA05004349A (https=)
NO (1) NO331297B1 (https=)
NZ (1) NZ539866A (https=)
PL (1) PL214867B1 (https=)
PT (1) PT1556382E (https=)
RS (1) RS51605B (https=)
SI (1) SI1556382T1 (https=)
TW (1) TWI325864B (https=)
UA (1) UA79317C2 (https=)
WO (1) WO2004041817A1 (https=)
ZA (1) ZA200503231B (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
FR2869316B1 (fr) * 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2876377B1 (fr) * 2004-10-11 2007-03-16 Univ Claude Bernard Lyon Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
HUE032426T2 (en) 2009-05-27 2017-09-28 Alkermes Pharma Ireland Ltd Inhibition of flake aggregation in nanoparticulate meloxicam formulations
FR2959133A1 (fr) 2010-04-22 2011-10-28 Sanofi Aventis Formulation pharmaceutique anticancereuse
FR2945950A1 (fr) 2009-05-27 2010-12-03 Elan Pharma Int Ltd Compositions de nanoparticules anticancereuses et procedes pour les preparer
CN107459481A (zh) * 2017-07-25 2017-12-12 广州大学 一种3‑（4‑甲氧基苯基）‑6‑甲氧基‑4‑氯‑5,7‑二溴喹啉的合成方法
CN113365997B (zh) * 2019-02-01 2022-06-07 南京明德新药研发有限公司 作为c-Met抑制剂的含嘧啶基团的三并环类化合物
CN113329276B (zh) * 2020-02-28 2022-10-28 华为技术有限公司 数据传输方法、装置、网关、芯片及存储介质
WO2022022687A1 (zh) * 2020-07-31 2022-02-03 南京明德新药研发有限公司 含嘧啶基团的三并环类化合物的盐型、晶型及其制备方法
CA3221565A1 (en) 2021-05-26 2022-12-01 Refined Technologies, Inc. Compositions and methods for removal of n-methyl-2-pyrrolidone (nmp) degradation products and other foulants from nmp purification systems

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
CA2187626C (en) 1994-04-13 2009-11-03 Michael G. Kaplitt Aav-mediated delivery of dna to cells of the nervous system
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
JP2002510686A (ja) 1998-04-02 2002-04-09 ニューロゲン コーポレイション アミノアルキルで置換された５，６，７，８−テトラヒドロ−９Ｈ−ピリジノ［２，３−ｂ］インドール及び５，６，７，８−テトラヒドロ−９Ｈピリミジノ［４，５−Ｂ］インドール誘導体：ＣＲＦ１特異的配位子
IT1313592B1 (it) * 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2869316B1 (fr) 2004-04-21 2006-06-02 Sanofi Synthelabo Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
FR2892416B1 (fr) 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
DE60321372D1 (de) 2008-07-10
HRP20050362B1 (hr) 2014-01-31
EP1556382B1 (fr) 2008-05-28
DK1556382T3 (da) 2008-10-06
JP4488899B2 (ja) 2010-06-23
AU2003296769B2 (en) 2010-02-04
PL214867B1 (pl) 2013-09-30
HRP20050362A2 (en) 2005-12-31
PT1556382E (pt) 2008-07-09
EP1556382A1 (fr) 2005-07-27
KR20050086421A (ko) 2005-08-30
CN100345850C (zh) 2007-10-31
TWI325864B (en) 2010-06-11
FR2846329B1 (fr) 2004-12-03
CY1109785T1 (el) 2014-09-10
IL168133A (en) 2010-05-31
PL376790A1 (pl) 2006-01-09
MEP22208A (en) 2010-06-10
NO331297B1 (no) 2011-11-21
JP2006511498A (ja) 2006-04-06
TW200413368A (en) 2004-08-01
MXPA05004349A (es) 2005-08-26
US20080214538A1 (en) 2008-09-04
HK1074446A1 (zh) 2005-11-11
EA010833B1 (ru) 2008-12-30
ES2304546T3 (es) 2008-10-16
NO20051983D0 (no) 2005-04-22
RS20050362A (sr) 2007-11-15
IS7815A (is) 2005-04-20
AU2003296769A1 (en) 2004-06-07
EA200500521A1 (ru) 2005-12-29
US8012991B2 (en) 2011-09-06
NO20051983L (no) 2005-07-22
ATE396994T1 (de) 2008-06-15
SI1556382T1 (sl) 2008-10-31
FR2846329A1 (fr) 2004-04-30
MA27455A1 (fr) 2005-07-01
IS2641B (is) 2010-08-15
UA79317C2 (en) 2007-06-11
KR101051859B1 (ko) 2011-07-25
BR0314883A (pt) 2005-08-02
CA2502769C (en) 2011-03-15
NZ539866A (en) 2008-01-31
AR041689A1 (es) 2005-05-26
CA2502769A1 (en) 2004-05-21
WO2004041817A1 (fr) 2004-05-21
US7390818B2 (en) 2008-06-24
ZA200503231B (en) 2006-06-28
CN1729190A (zh) 2006-02-01
US20050288318A1 (en) 2005-12-29
ME00102B (me) 2010-10-10

Similar Documents

Publication Publication Date Title
US8012991B2 (en) Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics
RU2146256C1 (ru) ПРОИЗВОДНЫЕ АЗОЛА И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ИХ ОСНОВЕ С АКТИВНОСТЬЮ В ОТНОШЕНИИ СЕРОТОНИНОВОГО (5-HT1Dα)РЕЦЕПТОРА
BRPI0720131A2 (pt) Glicocorticoides miméticos, métodos para fazê-los, composições farmacêuticas e usos dos mesmos.
AU2013354226A1 (en) Novel benzimidazole derivatives as EP4 antagonists
CN112409385A (zh) 氮杂芳基化合物及其应用
BRPI0718202A2 (pt) Derivados do fluoreno, composições que os contêm e uso como inibidores da proteína chaperona hsp90
CA2625502C (fr) Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique
ES2715348T3 (es) Compuestos que contienen anillos de nitrógeno fusionados para su uso como antagonistas de CRTH2
TW200418853A (en) Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
EP1742947A1 (fr) Derives de pyridoindolone substitues en -6, leur preparation, leur application en therapeutique.
HK1074446B (en) 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof